BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 19463275)

  • 1. [In vitro antifungal activity of micafungin].
    Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
    Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro antifungal activity of anidulafungin].
    Quindós G; Eraso E
    Rev Iberoam Micol; 2008 Jun; 25(2):83-91. PubMed ID: 18473502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Activity of micafungin against Candida biofilms].
    Quindós G; Villar-Vidal M; Eraso E
    Rev Iberoam Micol; 2009 Mar; 26(1):49-55. PubMed ID: 19463277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacodynamics and pharmacokinetics of micafungin in adults, children and neonate].
    Catalán-González M; Carlos Montejo-González J
    Rev Iberoam Micol; 2009 Mar; 26(1):23-34. PubMed ID: 19463274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro activity of anidulafungin. Comparison with the activity of other echinocandins].
    Martín Mazuelos E; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():7-13. PubMed ID: 19572429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Micafungin: experimental therapy of fungal infections in animal models].
    Javier Pastor F; Guarro J
    Rev Iberoam Micol; 2009 Mar; 26(1):42-8. PubMed ID: 19463276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinocandins--new antifungal agents.
    Stan CD; Tuchiluş C; Stan CI
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):528-36. PubMed ID: 25076727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Scientific evidence supporting the use of micafungin in the treatment of invasive candidiasis].
    Montejo M; Quindós G
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():15-22. PubMed ID: 21420572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micafungin: pharmacology, experimental therapeutics and clinical applications.
    Groll AH; Stergiopoulou T; Roilides E; Walsh TJ
    Expert Opin Investig Drugs; 2005 Apr; 14(4):489-509. PubMed ID: 15882123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echinocandins].
    Cortés L JA; Russi N JA
    Rev Chilena Infectol; 2011 Dec; 28(6):529-36. PubMed ID: 22286675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity profile in vitro of micafungin against Spanish clinical isolates of common and emerging species of yeasts and molds.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Monzon A; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2009 May; 53(5):2192-5. PubMed ID: 19223630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of micafungin and anidulafungin in the treatment of systemic fungal infections: applications and patents for two novel echinocandins.
    Hinske LC; Weis F; Heyn J; Hinske P; Beiras-Fernandez A
    Recent Pat Antiinfect Drug Discov; 2012 Apr; 7(1):1-7. PubMed ID: 22044354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.